Recombinate (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Recombinate drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | Antihemophilic Factor Recombinant |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2010-02-08 |
| END MARKETING DATE: | 0000-00-00 |
Recombinate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Recombinate from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2010-02-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0944-2831_6eb61ecd-d264-4163-ba11-26d4816062f3 |
| PRODUCT NDC: | 0944-2831 |
| APPLICATION NUMBER: | BLA103375 |